Show simple item record

Association of calcium antagonist use with lower hemoglobin levels in hemodialysis patients

dc.contributor.authorOzdemir, A. A.
dc.contributor.authorYalcin, B.
dc.contributor.authorAltay, M.
dc.contributor.authorGundogdu, A.
dc.contributor.authorErkal, S. N.
dc.contributor.authorKazancioglu, R.
dc.contributor.authorErkoc, R.
dc.contributor.authorCikrikcioglu, M. A.
dc.contributor.authorSekin, Y.
dc.date.accessioned2021-03-05T17:23:12Z
dc.date.available2021-03-05T17:23:12Z
dc.date.issued2015
dc.identifier.citationCikrikcioglu M. A. , Ozdemir A. A. , Sekin Y., Yalcin B., Altay M., Gundogdu A., Erkal S. N. , Kazancioglu R., Erkoc R., "Association of calcium antagonist use with lower hemoglobin levels in hemodialysis patients", MINERVA UROLOGICA E NEFROLOGICA, cilt.67, ss.187-196, 2015
dc.identifier.issn0393-2249
dc.identifier.otherav_c55493bf-870c-4c23-b602-f12efb3a8971
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/130841
dc.description.abstractAim. Objective of the present study was to investigate whether calcium antagonist use is associated with lower hemoglobin levels and/or higher erythropoiesis stimulating agent (ESA) requirement in hemodialysis patients.
dc.language.isoeng
dc.subjectDahili Tıp Bilimleri
dc.subjectÜROLOJİ VE NEFROLOJİ
dc.subjectKlinik Tıp
dc.subjectKlinik Tıp (MED)
dc.subjectTıp
dc.subjectSağlık Bilimleri
dc.subjectİç Hastalıkları
dc.subjectNefroloji
dc.titleAssociation of calcium antagonist use with lower hemoglobin levels in hemodialysis patients
dc.typeMakale
dc.relation.journalMINERVA UROLOGICA E NEFROLOGICA
dc.contributor.departmentBezmiâlem Vakıf Üniversitesi , ,
dc.identifier.volume67
dc.identifier.issue3
dc.identifier.startpage187
dc.identifier.endpage196
dc.contributor.firstauthorID224338


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record